Substantial statistical heterogeneity between studies was observed within each virus type (I2 = 98.1%, 83.9%, and 79.9% in critically ill patients for COVID-19, ACE2-associated, and non-ACE2-associated, respectively). Here, ACE2 is linked to COVID-19.